Skip to main content
Premium Trial:

Request an Annual Quote

BioMark Dx, TMIC Partner on Cancer Metabolomics Research

NEW YORK (GenomeWeb) – BioMark Diagnostics today announced it is partnering with The Metabolomics Innovation Centre on cancer research. 

The deal augments BioMark's efforts to discover, validate, and translate metabolomics-based diagnostic tests for early cancer detection, the Vancouver, British Columbia-based firm said, adding it "complements" its planned research into lung, prostate, breast, and colon cancer.  

In collaboration with TMIC, BioMark plans to develop novel point-of-care diagnostic tests. 

BioMark develops non-invasive technologies to detect cancers, monitor patients, and assess disease treatments. TMIC is a Genome Canada-funded Science & Technology Innovation Centre for metabolomics research, technology development, and services. Its technologies are based on mass spectrometry, NMR, gas chromatography, and novel bioinformatics tools. 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.